Primary pericardial malignant mesothelioma and response to radiation therapy

por Reardon, Kelli A, Reardon, Michael A, Moskaluk, Christopher A, Grosh, William W, Read, Paul W
Publicado 2010

Immunologic hierarchy and promiscuity of melanoma helper peptides

por Hu, Yinin, Petroni, Gina R, Olson, Walter C, Czarkowski, Andrea, Smolkin, Mark, Grosh, William W, Rehm, Patrice K, Murphy, Cheryl F, Coleman, Elizabeth J
Publicado 2013

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes

por Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Publicado 2013

A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes

por Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Publicado 2014

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist

por Meneveau, Max O, Petroni, Gina R, Salerno, Elise P, Lynch, Kevin T, Smolkin, Mark, Woodson, Elizabeth, Chianese-Bullock, Kimberly A, Olson, Walter C, Deacon, Donna, Patterson, James W, Grosh, William W, Slingluff, Craig L
Publicado 2021

Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

por Vavolizza, Rick D, Petroni, Gina R, Mauldin, Ileana S, Chianese-Bullock, Kimberly A, Olson, Walter C, Smith, Kelly T, Dengel, Lynn T, Haden, Kathleen, Grosh, William W, Kaur, Varinder, Varhegyi, Nikole, Gaughan, Elizabeth M, Slingluff, Craig L
Publicado 2022

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients

por Melssen, Marit M., Petroni, Gina R., Chianese-Bullock, Kimberly A., Wages, Nolan A., Grosh, William W., Varhegyi, Nikole, Smolkin, Mark E., Smith, Kelly T., Galeassi, Nadejda V., Deacon, Donna H., Gaughan, Elizabeth M., Slingluff, Craig L.
Publicado 2019

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)

por Slingluff, Jr., Craig L, Petroni, Gina R, Chianese-Bullock, Kimberly A, Wages, Nolan A, Olson, Walter C, Smith, Kelly T, Haden, Kathleen, Dengel, Lynn T, Dickinson, Anna, Reed, Caroline, Gaughan, Elizabeth M, Grosh, William W, Kaur, Varinder, Varhegyi, Nikole, Smolkin, Mark, Galeassi, Nadejda V, Deacon, Donna, Hall, Emily H
Publicado 2021